309 related articles for article (PubMed ID: 15048128)
1. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3.
Remy I; Montmarquette A; Michnick SW
Nat Cell Biol; 2004 Apr; 6(4):358-65. PubMed ID: 15048128
[TBL] [Abstract][Full Text] [Related]
2. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells.
Gajewska M; Motyl T
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067
[TBL] [Abstract][Full Text] [Related]
3. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis.
Conery AR; Cao Y; Thompson EA; Townsend CM; Ko TC; Luo K
Nat Cell Biol; 2004 Apr; 6(4):366-72. PubMed ID: 15104092
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
5. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
Zhang Y; Feng XH; Derynck R
Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
[TBL] [Abstract][Full Text] [Related]
6. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
Chen RH; Su YH; Chuang RL; Chang TY
Oncogene; 1998 Oct; 17(15):1959-68. PubMed ID: 9788439
[TBL] [Abstract][Full Text] [Related]
7. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
Schiller M; Verrecchia F; Mauviel A
Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
10. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
12. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.
Liu D; Black BL; Derynck R
Genes Dev; 2001 Nov; 15(22):2950-66. PubMed ID: 11711431
[TBL] [Abstract][Full Text] [Related]
15. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.
Zavadil J; Cermak L; Soto-Nieves N; Böttinger EP
EMBO J; 2004 Mar; 23(5):1155-65. PubMed ID: 14976548
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.
Ulloa L; Doody J; Massagué J
Nature; 1999 Feb; 397(6721):710-3. PubMed ID: 10067896
[TBL] [Abstract][Full Text] [Related]
17. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein.
Shen X; Hu PP; Liberati NT; Datto MB; Frederick JP; Wang XF
Mol Biol Cell; 1998 Dec; 9(12):3309-19. PubMed ID: 9843571
[TBL] [Abstract][Full Text] [Related]
19. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.
Song K; Wang H; Krebs TL; Danielpour D
EMBO J; 2006 Jan; 25(1):58-69. PubMed ID: 16362038
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling.
Sun Y; Liu X; Eaton EN; Lane WS; Lodish HF; Weinberg RA
Mol Cell; 1999 Oct; 4(4):499-509. PubMed ID: 10549282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]